WO2011091131A3 - Eslicarbazepine acetate and its polymorphs - Google Patents
Eslicarbazepine acetate and its polymorphs Download PDFInfo
- Publication number
- WO2011091131A3 WO2011091131A3 PCT/US2011/021852 US2011021852W WO2011091131A3 WO 2011091131 A3 WO2011091131 A3 WO 2011091131A3 US 2011021852 W US2011021852 W US 2011021852W WO 2011091131 A3 WO2011091131 A3 WO 2011091131A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- eslicarbazepine acetate
- polymorphs
- preparation
- eslicarbazepine
- acetate
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
- C07D223/14—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
- C07D223/18—Dibenzazepines; Hydrogenated dibenzazepines
- C07D223/22—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines
- C07D223/24—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom
- C07D223/28—Dibenz [b, f] azepines; Hydrogenated dibenz [b, f] azepines with hydrocarbon radicals, substituted by nitrogen atoms, attached to the ring nitrogen atom having a single bond between positions 10 and 11
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Processes for the preparation of eslicarbazepine acetate and intermediates thereof. Also provided are polymorphic forms of eslicarbazepine acetate and methods for their preparation.
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN155/CHE/2010 | 2010-01-23 | ||
IN155CH2010 | 2010-01-23 | ||
US32016010P | 2010-04-01 | 2010-04-01 | |
US61/320,160 | 2010-04-01 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011091131A2 WO2011091131A2 (en) | 2011-07-28 |
WO2011091131A3 true WO2011091131A3 (en) | 2011-12-22 |
Family
ID=44307578
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2011/021852 WO2011091131A2 (en) | 2010-01-23 | 2011-02-08 | Eslicarbazepine acetate and its polymorphs |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2011091131A2 (en) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2011138795A2 (en) * | 2010-05-03 | 2011-11-10 | Msn Laboratories Limited | Process for preparing (s)-10-acetoxy-10,11-dihydro-5h-dibenz[b,f] azepine-5-carboxamide |
WO2012121701A1 (en) * | 2011-03-07 | 2012-09-13 | Watson Laboratories, Inc. | Process for the resolution of racemic (±)-10,11-dihydro-10-hydroxy-5h-dibenz[b,f]azepine-5-carboxamide |
US9346760B2 (en) | 2011-03-08 | 2016-05-24 | Jubilant Life Sciences Limited | Process for the preparation of (S)-(+)- or (R)-(-)-10-hydroxy dihydrodibenz[B,F]azepines by enantioselective reduction of 10,11-dihydro-10-OXO-5H-dibenz[B,F]azepines and polymorphs thereof |
WO2012156987A2 (en) * | 2011-05-19 | 2012-11-22 | Glenmark Generics Limited | A novel process for the preparation of eslicarbazepine |
US20150065704A1 (en) * | 2011-07-13 | 2015-03-05 | Ketan Hirpara | Process for the preparation and purification of eslicarbazepine acetate and intermediates thereof |
WO2013158473A1 (en) * | 2012-04-16 | 2013-10-24 | Shell Oil Company | Lubricant compositions containing ionic liquids |
IN2015DN02296A (en) | 2012-09-26 | 2015-08-21 | Ranbaxy Lab Ltd | |
US9409913B2 (en) * | 2012-11-21 | 2016-08-09 | Enaltec Labs Private Limited | Polymorphic forms of alcaftadine |
EP3064490A1 (en) | 2015-03-06 | 2016-09-07 | F.I.S.- Fabbrica Italiana Sintetici S.p.A. | Improved process for the preparation of eslicarbazepine and eslicarbazepine acetate |
Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753646A (en) * | 1995-06-30 | 1998-05-19 | Portela & Ca., S.A. | Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
WO2006005951A1 (en) * | 2004-07-13 | 2006-01-19 | Portela & C.A. S.A. | Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof |
US7119197B2 (en) * | 2001-05-11 | 2006-10-10 | Portela & C.A., S.A. | Method for preparation of (s)-(+)-and(r)-(-)10,11-dihydro-10-hydrodoxy-5h-dibenz/b,f/azephine-5-carboxamide |
WO2007012793A1 (en) * | 2005-07-29 | 2007-02-01 | Portela & C.A., S.A. | Asymmetric catalytic reduction of oxcarbazepine |
WO2007117166A1 (en) * | 2006-04-11 | 2007-10-18 | Bial - Portela & C.A., S.A. | Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation |
WO2010113179A2 (en) * | 2009-04-02 | 2010-10-07 | Glenmark Generics Limited | A process for the purification of eslicarbazepine acetate |
-
2011
- 2011-02-08 WO PCT/US2011/021852 patent/WO2011091131A2/en active Application Filing
Patent Citations (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5753646A (en) * | 1995-06-30 | 1998-05-19 | Portela & Ca., S.A. | Substituted dihydrodibenzo/b,f/azepines, method of their preparation, their use in the treatment of some central nervous system disorders, and pharmaceutical compositions containing them |
US7119197B2 (en) * | 2001-05-11 | 2006-10-10 | Portela & C.A., S.A. | Method for preparation of (s)-(+)-and(r)-(-)10,11-dihydro-10-hydrodoxy-5h-dibenz/b,f/azephine-5-carboxamide |
WO2006005951A1 (en) * | 2004-07-13 | 2006-01-19 | Portela & C.A. S.A. | Method for chiral inversion of (s)-(+)- and (r)-(-)-10,11-dihydro-10-hydroxy-5h-dibenz/b,f/azepine-5-carboxamide and optically enriched mixtures thereof |
WO2007012793A1 (en) * | 2005-07-29 | 2007-02-01 | Portela & C.A., S.A. | Asymmetric catalytic reduction of oxcarbazepine |
WO2007117166A1 (en) * | 2006-04-11 | 2007-10-18 | Bial - Portela & C.A., S.A. | Preparation of eslicarbazepine and related compounds by asymmetric hydrogenation |
WO2010113179A2 (en) * | 2009-04-02 | 2010-10-07 | Glenmark Generics Limited | A process for the purification of eslicarbazepine acetate |
Also Published As
Publication number | Publication date |
---|---|
WO2011091131A2 (en) | 2011-07-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010122578A3 (en) | Process for preparation of sitagliptin and its intermediates | |
WO2011091131A3 (en) | Eslicarbazepine acetate and its polymorphs | |
EP2758385A4 (en) | Process for the preparation of triazole antifungal drug, its intermediates and polymorphs thereof | |
IL215999A0 (en) | Processes for the preparation of rivaroxaban and intermediates thereof | |
EP2774203B8 (en) | Method for the preparation of catalyst-coated membranes | |
ZA201201542B (en) | Novel polymorphs of rebaudioside c and methods for making and using the same | |
IL202664A (en) | Processes for the preparation of 3-dihalomethyl-1-methyl-1h- pyrazole-4-carbaldehyde and intermediates | |
WO2012038975A3 (en) | Processes for the preparation of asenapine and intermediates thereof | |
WO2010062715A3 (en) | Polymorphs of dasatinib and process for preparation thereof | |
WO2012025944A3 (en) | Sitagliptin, salts and polymorphs thereof | |
HUP1000330A2 (en) | Process for the preparation of dronedarone and the novel intermediates | |
SI2346850T1 (en) | Method for the preparation of dabigatran and its intermediates | |
WO2010078396A3 (en) | Compounds, intermediates, and methods of preparing the same | |
IL221141A0 (en) | Methods of synthesizing and isolating n-(bromoacetyl)-3,3-dinitroazetidine and a composition including the same | |
IL222649A0 (en) | Saxagliptin intermediates, saxagliptin polymorphs, and processes for preparation thereof | |
EP2509423A4 (en) | Processes for the preparation of deferasirox, and deferasirox polymorphs | |
EP2630143A4 (en) | Processes for the preparation of rivaroxaban and intermediates thereof | |
EP3214066B8 (en) | Process for the preparation of fluoroalkyl fluoroformates | |
EP2528923A4 (en) | Process for the preparation of darunavir and darunavir intermediates | |
WO2010016931A3 (en) | Polymorphs of fluticasone furoate and process for preparation thereof | |
PT3656758T (en) | Intermediates for the preparation of c-terminal hsp90 inhibitors | |
EP2090567A3 (en) | Processes for the preparation of intermediates of valsartan | |
WO2011023954A3 (en) | Polymorphic forms of manidipine | |
IL221184A (en) | Process for the preparation of 5-substituted 1-alkyltetrazoles | |
WO2011100282A3 (en) | Imatinib mesylate polymorphs |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 11735167 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 11735167 Country of ref document: EP Kind code of ref document: A2 |